Pages that link to "Q34520933"
Jump to navigation
Jump to search
The following pages link to Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs (Q34520933):
Displaying 50 items.
- N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase (Q24569817) (← links)
- Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase (Q24620186) (← links)
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin (Q24643876) (← links)
- 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats (Q24644922) (← links)
- Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter (Q24644993) (← links)
- The impact of gonadal hormones on cannabinoid dependence (Q27333539) (← links)
- The effects of cannabinoids on the brain (Q28137626) (← links)
- Cannabinoid receptors and pain (Q28143655) (← links)
- Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol (Q28145410) (← links)
- Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats (Q28199611) (← links)
- Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine (Q28202741) (← links)
- The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (Q28236199) (← links)
- Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice (Q28343324) (← links)
- HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor (Q28343769) (← links)
- 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor (Q28369726) (← links)
- Synthesis and pharmacology of a hybrid cannabinoid (Q28373461) (← links)
- Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats (Q28551268) (← links)
- Evaluation of sex differences in cannabinoid dependence. (Q30415208) (← links)
- Tuberoinfundibular peptide of 39 residues (TIP39) signaling modulates acute and tonic nociception (Q30473257) (← links)
- Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse (Q30569742) (← links)
- Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues (Q33486662) (← links)
- Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice (Q33583810) (← links)
- The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential (Q33643168) (← links)
- Discovery and characterization of endogenous cannabinoids (Q33720094) (← links)
- In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability (Q33751118) (← links)
- Towards cannabinoid drugs--revisited. (Q33906007) (← links)
- Sex differences in Δ(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats (Q33931336) (← links)
- Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents (Q33948790) (← links)
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity (Q34028741) (← links)
- "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays (Q34055910) (← links)
- Synthesis and pharmacology of 1-methoxy analogs of CP-47,497. (Q34059803) (← links)
- Endocannabinoid signalling: has it got rhythm? (Q34098217) (← links)
- JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects. (Q34098379) (← links)
- Development of a high-performance liquid chromatography-tandem mass spectrometry method for the identification and quantification of CP-47,497, CP-47,497-C8 and JWH-250 in mouse brain (Q34106241) (← links)
- Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol (Q34125281) (← links)
- Operant nociception in nonhuman primates (Q34150516) (← links)
- The cannabinoid receptors. (Q34159121) (← links)
- Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist (Q34162470) (← links)
- Survey of current trends in the abuse of psychotropic substances and plants in Japan (Q34168717) (← links)
- 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor (Q34171749) (← links)
- Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to 'buzz' smoke by HPLC/MS/MS. (Q34190857) (← links)
- Rational Design and Synthesis of an Orally Active Indolopyridone as a Novel Conformationally Constrained Cannabinoid Ligand Possessing Antiinflammatory Properties (Q34196919) (← links)
- 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism (Q34232856) (← links)
- Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure (Q34233915) (← links)
- 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice (Q34236794) (← links)
- A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. (Q34264449) (← links)
- BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury. (Q34280204) (← links)
- Drugs of abuse and increased risk of psychosis development. (Q34290364) (← links)
- 1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor (Q34298682) (← links)
- Diuretic effects of cannabinoids (Q34302379) (← links)